EDDA Technology has announced the commercial release of IQQA(R)-Chest software V2.0 featuring enterprise CAD solution for digital X-ray. IQQA(R)-Chest is the only FDA cleared system to offer real-time interactive diagnostic analysis of digital chest X-rays using a comprehensive set of tools to support radiologists in their identification, confirmation and quantification of lung nodules. IQQA(R)-Chest has clinically demonstrated an ability to improve radiologists' detection of small lung nodules (5-15mm) up to 85 percent.

Powered with the same computer-assisted detection support software of the debut software V1.0, IQQA(R)-Chest Enterprise aims to redefine how advanced clinical applications can and should be accessed by radiologists. Up to now, radiologists have simply had to accept that the use of advanced imaging software meant they would have to operate at dedicated workstations detached from their primary PACS review stations. Although static image results could often be sent from these stand-alone workstations back to a PACS for review, it was still not possible to enjoy access to the full functionality of these advanced applications at the PACS viewing station.

Responding to this clinical challenge, EDDA has developed a unique enabling solution capable of instantly deploying the full functionality of the IQQA(R)-Chest application on existing PACS review consoles without additional requirement or setup effort on the workstations.


According to Dr. Edwin van Beek, Professor of Radiology, University of Iowa Hospital and Clinics, the need for this level of performance is particularly critical with chest radiography, the most frequently performed imaging study. University of Iowa Hospital and Clinics, a commercial site of EDDA's, has recently been upgraded to IQQA(R)-Chest Enterprise.

"With the number of chest X-rays we read on a daily basis, to maximize the benefit from a CAD application will be highly dependent upon the accessibility we have to the full application at our PACS review stations," added Dr. van Beek. "EDDA has cleared this hurdle with IQQA(R)-Chest Enterprise. The immediacy we now enjoy with this tool allows us to expand our use of the application at the University of Iowa with the prospect of further enhancing our overall detection rate."

Dr. van Beek and his colleagues will report on a clinical study conducted at the University of Iowa in which the software was used in their daily practice since January 2006. The study suggests that the software could help residents detect approximately 20% more small lung nodules. The results have been accepted for presentation at the upcoming RSNA 2006 meeting.

More Voices